News Chart Oncodesign Precision Medicine

Equities

ALOPM

FR001400CM63

Real-time Euronext Paris Other stock markets 09:44:10 2024-05-20 am EDT			5-day change	1st Jan Change
1.32 ^EUR	+1.54%		-4.35%	-27.07%

May. 15	Oncodesign Precision Medicine and Navigo Proteins GmbH Sign A Strategic Collaboration Agreement for the Research and Development of New Systemic Radiotherapy Agents	CI
Jan. 25	Oncodesign Precision Medicine: fundraising on the horizon	CF

2426ae016dff1f7ba74619acb546520.nshG3m63d9fs2eKw73WvQQM6HEtQbMNDYxPlWtK7HSY.7Kcxqxb4Wpqgt4PgrACCGHpeaiE-Jps3OliuLLTCfnP0nxeyAs07uZq4ow~a9e4996913c62191c14a704c84b130e5